Blood may be transfused as whole blood or as one of its
many components. Up to four components may be derived from one unit of blood. These
include:
- red blood cells
- plasma
- platelets
- cryoprecipitated antihemophilic factor (AHF)
Since patients seldom require all of the components of
whole blood, it makes sense to transfuse only that portion of blood needed by the patient
for a specific condition or disease, saving the remaining components of the blood for
other patients in need. This treatment, referred to as "blood component
therapy," allows several patients to benefit from one unit of donated whole blood.
Improvements in cell preservative solutions over the last 15 years have increased the
shelf life of red blood cells from 35 to 42 days.
All About Blood
Whole blood is living tissue circulating through the
heart, arteries, veins, and capillaries carrying nourishment, electrolytes, hormones,
vitamins, antibodies, heat, and oxygen to the body's tissues. Whole blood contains red
blood cells, white blood cells and platelets suspended in a watery fluid called plasma.
If blood is treated to prevent clotting and permitted to stand in a container, the red
blood cells, weighing the most, will settle to the bottom; the plasma will stay on top;
and the white blood cells and platelets will remain suspended between the plasma and the
red blood cells. A centrifuge may be used to hasten this separation process. The
platelet-rich plasma is then removed and placed into a sterile bag, and it can be used to
prepare platelet concentrates and cryoprecipitated anti-hemophilic factor (AHF).
To make platelets, the platelet-rich plasma is centrifuged, causing the platelets to
settle at the bottom of the bag. Plasma and platelets are then separated and made
available for transfusion. The plasma may also be pooled with plasma from other donors and
further processed, or fractionated, to provide purified plasma proteins such as albumin,
immunoglobulin, and clotting factors.
Red Blood Cells
Red blood cells (RBCs) are perhaps the most recognizable
component of whole blood. RBCs contain hemoglobin, a complex iron-containing protein that
carries oxygen throughout the body and gives blood its red color.
The percentage of blood volume composed of red blood cells is called the
"hematocrit." The average hematocrit in an adult male is 47 percent. There are
about one billion red blood cells in two to three drops of blood, and for every 600 red
blood cells, there are about 40 platelets and one white cell. RBCs may be treated and
frozen for extended storage, up to 10 years.
Manufactured in the bone marrow, RBCs are continuously produced and broken down. They
live for about 120 days in the circulatory system and are eventually removed by the
spleen. Red blood cells are prepared from whole blood by removing the plasma, or the
liquid portion of the blood, and can raise the patient's hematocrit and hemoglobin levels
while minimizing an increase in blood volume.
Patients who benefit most from transfusions of red blood cells include those with
chronic anemia resulting from kidney failure, malignancies or gastrointestinal bleeding
and those with acute blood loss resulting from trauma. Since red blood cells have reduced
amounts of plasma, they are well-suited for treating anemia patients who would not
tolerate the increased volume provided by whole blood, such as patients with congestive
heart failure or those who are elderly or debilitated.
Prestorage Leuko-Reduced Red Blood Cells
This form of RBCs requires special preparation by
removing leukocytes (white blood cells) by filtration within 48 hours of donation. This is
done because high numbers of leukocytes remaining in a unit of RBCs during the storage
process can fragment and deteriorate cytokines (chemicals that effect the inflammatory
response.) Fragments of leukocytes have been implicated as a cause of blood recipients
developing allergies to subsequent blood transfusions. White blood cells can
carry viruses that can infect the transfusion recipient. Leuko-reduction
greatly reduces the chance of adverse transfusion reaction, reduces the likelihood
of a patient having to use antibiotics and had been shown to reduce the length
of hospital stays.
Plasma
Plasma is the liquid portion of the blood--a protein-salt
solution in which red and white blood cells and platelets are suspended. Plasma, which is
90 percent water, constitutes 55 percent of blood volume. Plasma contains albumin (the
chief protein constituent,) fibrinogen (responsible, in part, for the clotting of blood)
and globulins (including antibodies.) Plasma serves a variety of functions, from
maintaining a satisfactory blood pressure and volume, to supplying critical proteins for
blood clotting and immunity. It also serves as the medium of exchange for vital minerals
such as sodium and potassium, helping maintain a proper balance in the body, which is
critical to cell function.
Plasma is obtained by separating the liquid portion of blood from the cells. Fresh
frozen plasma (FFP) is frozen shortly after donation to preserve clotting factors, stored
up to one year and thawed just before use. It is transfused for bleeding disorders which
have no factor-specific concentrate treatment.
Cryoprecipitate
Cryoprecipitate is the portion of plasma rich in clotting
factors, including Factor VIII and fibrinogen. "Cryo" is removed from plasma by
freezing and then slowly thawing the plasma. It is used to prevent or control bleeding in
those with hemophilia and von Willebrand syndromes, the most common inherited major
coagulation abnormalities. Another use is to mix it with thrombin. Called fibrosealant, it
is applied at a wound site to prevent bleeding.
Platelets
Platelets (or thrombocytes) are small blood components
that help the clotting process by sticking to the lining of blood vessels. Platelets are
made in the bone marrow and survive in the circulatory system for about nine days before
being removed from the body by the spleen. The platelet helps prevent massive blood loss
and blood vessel leakage resulting from trauma.
Platelets are prepared by using a centrifuge to separate the platelet-rich plasma from
the donated unit of whole blood. The platelet-rich plasma is then centrifuged again to
concentrate the platelets further. Platelets may also be obtained from a donor by a
process known as apheresis, or platelet pheresis. In this process, blood is drawn from the
donor into an apheresis instrument, which, using centrifugation, separates the blood into
its components, retains the platelets, and returns the remainder of the blood to the
donor. The resulting component contains about six times as many platelets as a unit of
platelets obtained from whole blood.
Platelets are used to treat a condition called thrombocytopenia, in which there is a
shortage of platelets, and platelet function abnormalities. Platelets are stored at room
temperature for up to five days.
White Blood Cells
White blood cells are responsible for protecting the body
from invasion by foreign substances such as bacteria and viruses. The majority of white
blood cells are produced in the bone marrow, where they outnumber red blood cells by 2 to
1. However, in the blood stream, there are about 600 red blood cells for every white blood
cell.
There are several types of white blood cells. Granulocyte and macrophages protect
against infection by surrounding and destroying invading bacteria and viruses, and
lymphocytes aid in the immune defense. Granulocyte are prepared by apheresis or by
centrifugation of whole blood. They are transfused within 24 hours after collection and
are used for infections that are unresponsive to antibiotic therapy. The effectiveness of
white blood cell transfusion is still being investigated.
Plasma Derivatives
Plasma derivatives are concentrates of specific plasma
proteins prepared from pools (many units) of plasma. Plasma derivatives are obtained
through a process, known as fractionation, developed during World War II, and are
heat-treated and/or solvent detergent-treated to kill certain viruses, like those that
cause AIDS and hepatitis B and C. Plasma derivatives include:
|